PEGFILGRASTIM-APGF for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-APGF was used for Neoplasm malignant.
Most Reported Side Effects for PEGFILGRASTIM-APGF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 18 | 15.0% | 16 | 0 |
| Device leakage | 9 | 7.5% | 0 | 0 |
| Drug dose omission by device | 9 | 7.5% | 0 | 0 |
| Pyrexia | 8 | 6.7% | 0 | 8 |
| Off label use | 6 | 5.0% | 1 | 0 |
Other Indications for PEGFILGRASTIM-APGF
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)